Literature DB >> 9915771

Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x.

D J Ing1, J Zang, V J Dzau, K A Webster, N H Bishopric.   

Abstract

-Cytokine-induced NO production depresses myocardial contractility and has been shown to be cytotoxic to cardiac myocytes. However, the mechanisms of cytokine-induced cardiac myocyte cell death are unclear. To analyze these mechanisms in detail, we treated neonatal cardiac myocytes in serum-free culture with a combination of the macrophage-derived cytokines interleukin-1beta, tumor necrosis factor-alpha, and interferon-gamma. These cytokines caused a time-dependent induction of cardiac myocyte apoptosis, but not necrosis, beginning 72 hours after treatment, as determined by nuclear morphology, DNA internucleosomal cleavage, and cleavage of poly(ADP-ribose) polymerase, reflecting caspase activation. Apoptosis was preceded by a >50-fold induction of inducible NO synthase mRNA and the release of large amounts (5 to 8 nmol/ microgram protein) of NO metabolites (NOx) into the medium. Cell death was completely blocked by an NO synthase inhibitor and attenuated by antioxidants (N-acetylcysteine and DTT) and the caspase inhibitor ZVAD-fmk. Cytokines also mediated an NO-dependent, sustained increase in myocyte expression of the Bcl-2 homologs Bak and Bcl-x(L). The NO donor S-nitrosoglutathione also induced apoptosis and cell levels of Bak, but not of Bcl-x(L). All effects of cytokines, including poly(ADP-ribose) polymerase cleavage, could be attributed to interleukin-1beta; interferon-gamma and tumor necrosis factor-alpha had no independent effects on apoptosis or on NOx production. We conclude that cytokine toxicity to neonatal cardiac myocytes results from the induction of NO and subsequent activation of apoptosis, at least in part through the generation of oxygen free radicals. The rate and extent of this apoptosis is modulated by alterations in the cellular balance of Bak and Bcl-x(L), which respond differentially to cytokine-induced and exogenous NO and by the availability of oxidant species.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9915771     DOI: 10.1161/01.res.84.1.21

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  50 in total

Review 1.  Molecular and cellular mechanisms of myocardial remodeling.

Authors:  Melanie Maytin; Wilson S Colucci
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

Review 2.  Nitric oxide, cell death, and heart failure.

Authors:  Jun-ichi Oyama; Stefan Frantz; Charles Blais; Ralph A Kelly; Todd Bourcier
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

3.  Pathways involved in interleukin-1β-mediated murine cardiomyocyte apoptosis.

Authors:  Yi Shen; Jie Qin; Peili Bu
Journal:  Tex Heart Inst J       Date:  2015-04-01

Review 4.  Cardiovascular Complications of COVID-19 and Associated Concerns: A Review.

Authors:  Wen-Liang Yu; Han Siong Toh; Chia-Te Liao; Wei-Ting Chang
Journal:  Acta Cardiol Sin       Date:  2021-01       Impact factor: 2.672

Review 5.  Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure.

Authors:  Toshinori Aoyagi; Takashi Matsui
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 6.  The role of interleukin-1 in the failing heart.

Authors:  C S Long
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

7.  Nitric oxide and promotion of cardiac myocyte apoptosis.

Authors:  Péter Andréka; Thanh Tran; Keith A Webster; Nanette H Bishopric
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

8.  Sequential expression of TLR4 and its effects on the myocardium of rats with myocardial ischemia-reperfusion injury.

Authors:  Jun Yang; Jian Yang; Jia-wang Ding; Li-hua Chen; Yan-lin Wang; Song Li; Hui Wu
Journal:  Inflammation       Date:  2008-10       Impact factor: 4.092

9.  Nitric oxide induces cell death by regulating anti-apoptotic BCL-2 family members.

Authors:  Colleen M Snyder; Emelyn H Shroff; Jing Liu; Navdeep S Chandel
Journal:  PLoS One       Date:  2009-09-21       Impact factor: 3.240

10.  Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders.

Authors:  Wilfried Dinh; Reiner Füth; Werner Nickl; Thomas Krahn; Peter Ellinghaus; Thomas Scheffold; Lars Bansemir; Alexander Bufe; Michael Coll Barroso; Mark Lankisch
Journal:  Cardiovasc Diabetol       Date:  2009-11-12       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.